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ABSTRACT
PURPOSE: To investigate the effects of ischemic preconditioning (IPC) on the expression of pro and anti-apoptotic genes in rat 
endothelial cells undergoing enteric ischemia (I) and reperfusion (R).
METHODS: Thirty rats underwent clamping of the superior mesenteric vessels. Sham group (GS) laparotomy only; Ischemia (GI): 
intestinal ischemia (60 min); Ischemia and Reperfusion (GIR): ischemia (60 min) and reperfusion (120 min);  Ischemia and intestinal 
ischemic preconditioning (GI + IPC) : 5 minutes of ischemia followed by 10 min of reperfusion before sustained ischemia (60 min) 
ischemia and reperfusion and IPC (GIR + IPC): 5 min ischemia followed by 10 min of reperfusion before sustained ischemia (60min) 
and reperfusion (120 min). Rat Endothelial Cell Biology (PCR array) to determine the expression of genes related to endothelial cell 
biology.
RESULTS: Gene expression of pro-apoptotic markers (Casp1, Casp6, Cflar, Fas, and Pgl) was down regulated in GI+IPC and in GIR + 
IPC. In contrast, the expression of anti-apoptotic genes (Bcl2 and Naip2), was up-regulated in GI + IPC and in GIR + IPC. 
CONCLUSION: Ischemic preconditioning may protect against cell death caused by ischemia and reperfusion.
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Introduction
Ischemia followed by reperfusion (I/R) promotes multiple 
biological responses that cause tissue injury and organ damage. 
These responses include the generation of reactive oxygen species 
(ROS), the activation of transcription factors, the production 
of cytokines and eicosanoids, the expression of inducible nitric 
oxide synthase (NOS) and adhesion molecules, injury to blood 
vessel endothelium, neutrophil infiltration, platelet adhesion, 
microscopic circulating deficit, and apoptosis1. In the intestine, 
I/R injury is the major factor responsible for intestinal dysfunction 
and is a determinant of patient prognosis after transplantation. 
Thus, novel strategies to prevent or ameliorate intestinal I/R 
injury are necessary to improve patient outcomes following organ 
transplantation2,3.
I/R injury is considered to be the principal trigger of 
systemic inflammatory response syndrome (SIRS) and is a crucial 
process associated with an increased incidence of chronic rejection 
after transplantation. SIRS often progresses to multiple organ 
failure, resulting in up to 80% mortality1. Reperfusion of ischemic 
tissues is often associated with microvascular dysfunction that 
manifests as impaired endothelium-dependent dilation in arterioles, 
enhanced fluid filtration and leukocyte plugging in capillaries, and 
leukocyte trafficking and plasma protein extravasations in post 
capillary venules1.
Endothelial cells modulate many important vascular 
functions, such as vascular tone, inflammation, homeostasis, and 
angiogenesis4. Activated endothelial cells in all segments of the 
microcirculation produce more oxygen radicals, but less nitric 
oxide, in the initial period following reperfusion. The resulting 
imbalance between superoxide and nitric oxide in endothelial cells 
leads to the production and release of inflammatory mediators 
(e.g., platelet-activating factor and tumor necrosis factor) and 
enhances the biosynthesis of adhesion molecules that mediate 
leukocyte-endothelial cell adhesion1.
The inflammatory mediators released as a consequence 
of reperfusion also appear to activate endothelial cells in remote 
organs that are not exposed to the initial ischemic insult1. This 
remote response to I/R can result in the leukocyte-dependent 
microvascular injury that is characteristic of multiple organ 
dysfunction syndrome1.
Intestinal I/R injury is multifactorial and involves 
impaired blood flow reconstitution, increased expression of 
adhesion molecules, neutrophil activation, activation of antigen-
presenting cells (APCs), cytokine/chemokine release by infiltrating 
leukocytes, oxidative stress, and endothelial cell apoptosis2,3. It is 
assumed that the initial endothelial damage plays a pivotal role in 
intestinal I/R, but limited access to endothelial tissue is a major 
constraint when investigating the cellular mechanisms of vascular 
inflammation4.
In 1986, Murry et al.5 observed that ischemic 
preconditioning (IPC) for a short duration before long-term 
I/R reduced the severity of the subsequent I/R injury. This 
phenomenon has since been documented in a variety of organs. 
Because it is easy, efficient, and cost-effective, IPC has been 
used in clinical medicine. The duration of IPC necessary to 
acquire tolerance to ischemia differs for every internal organ. 
There are two temporally and mechanistically distinct types 
of protection afforded by this adaptive response: acute and 
delayed preconditioning. In general, the protective effects of 
acute preconditioning are independent of protein synthesis, 
whereas the effects of delayed preconditioning require protein 
synthesis6. Some factors, such as protein kinase C, are involved 
in both types of preconditioning responses6. Despite intensive 
research, the exact cellular and biochemical mechanisms by which 
IPC confers protection in the intestine have not been elucidated. 
A clearer understanding of cellular signaling during 
intestinal I/R could provide better insight into the protective 
mechanism of IPC. Recent studies have shown that the use of 
the quantitative real time polymerase chain reaction method 
(qRT-PCR) to evaluate specific gene expression during I/R could 
be crucial to understanding the protective mechanism of IPC.6 
In the present work, we used the Rat Endothelial Cell Biology 
PCR Array to characterize gene expression in endothelial cells 
in rats subjected to IPC prior to intestinal I/R injury. This array 
profiles the expression of 84 genes related to endothelial cell 
biology and includes genes involved in permissibility and vessel 
tone, angiogenesis, endothelial cell activation and endothelial cell 
injury. 
Methods
The experimental protocol (0109/11) was approved 
by the Ethics Committee of the Federal University of Sao 
Paulo (UNIFESP), on according to the recommendations of 
the international legislations on animal protection. The study 
was designed as a randomized controlled trial with a blinded 
assessment of the outcome. 
Thirty male Wistar-EPM1 rats (Center for the 
Development of Experimental Models for Medicine and Biology 
- CEDEME-UNIFESP) that weighed 250 to 300g were housed 
under controlled temperature and light conditions with a 12-h 
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light-dark cycle. The animals had free access to water and 
standard pellet chow until 6 h prior to the surgical procedures. 
All procedures were conducted in the laboratories of Experimental 
Surgery, Department of Surgery (UNIFESP). 
The animals underwent anesthesia, laparotomy, and 
exposure of the upper mesenteric vessels and were randomly 
assigned to one of five groups:
1. Sham group (SG): six animals with exposure 
of the upper mesenteric vessels without clamping of the upper 
mesenteric vessels;
2. Ischemia group (IG): six animals in which the 
upper mesenteric vessels were clamped for 60 min; 
3. Ischemia and reperfusion group (IRG): six 
animals in which the upper mesenteric vessels were clamped for 
60 min, followed by 120 min of reperfusion;
4. Ischemia and intestinal preconditioning group 
(IG+IPC): six animals exposed to 5 min of ischemia followed by 
10 min of reperfusion before the sustained 60 min of ischemia;
5. Ischemia and reperfusion and IPC group 
(IRG+IPC): six animals subjected to 5 min of ischemia followed 
by 10 min of reperfusion before starting the sustained 60 min of 
ischemia and 120 min of reperfusion.
Anesthesia and surgical procedures
After 6h of fasting for solids and liquids, the animals 
were anesthetized with an intramuscular injection of a mixture 
containing 80 mg/kg ketamine and 10 mg/kg xylazine and 
provided with oxygen through a mask. Body temperature was 
maintained at 37.8oC using a homeothermic soft blanket (40 x 70 
cm) and monitored with a rectal temperature probe. 
Under aseptic conditions, all 30 animals underwent a 
midline laparotomy. The upper mesenteric vessels were carefully 
dissected, and the mesenteric artery and vein were identified and 
occluded with small vascular clamps. Ischemia was confirmed 
by observing the pale appearance of the clamped intestine and 
the lack of arterial beating. After 60 min of ischemia, the clamps 
were removed, and reperfusion was evaluated based on immediate 
color recovery and arterial beating. The surgical wounds remained 
covered with wet gauze wrappings throughout the experiment to 
minimize evaporative loss. 
After each procedure, intestinal segments were removed 
20 cm from the duodenum-jejunum flexure. A 3-cm jejunal 
segment was opened longitudinally, gently washed in saline 
solution, wrapped in aluminum foil, and placed in liquid nitrogen 
in less than 1.5 min. 
After the samples were collected, the animals received an 
intravenous injection (0.3 ml/kg) of a combination of embutamide, 
mebezone and tetracain which promotes rapid death.
RNA preparation and quantitative real-time RT-PCR 
The Rat Endothelial Cell Biology RT² Profiler™ PCR 
array from SABiosciences (Frederick, Maryland; catalog # PAMM-
065) was performed according to the manufacturer’s protocol. 
Briefly, total RNA was extracted from S and I/R small bowel 
tissues using TRIzol reagent (Life Technologies, Grand Island, NY, 
USA) and purified using an RNeasy MiniKit (QIAGEN, USA). 
The concentration of each total RNA sample was determined by 
spectrophotometer, and the quality was assessed by electrophoresis 
on 2% agarose gels. The first strand complementary DNA (cDNA) 
was synthesized using 1 µg of total RNA and the RT² First Strand 
Kit (SABiosciences). Equal amounts of cDNA and the Master 
Mix SYBR® Green qPCR Mastermix (SABiosciences, QIAGEN 
Company) were distributed to each well of the PCR array plate 
containing the pre-dispensed gene-specific primer sets. PCR was 
performed according to the manufacturer’s instructions in 96-well 
plates to detect the expression of 84 genes related to oxidative 
stress, five housekeeping genes (ACTB, Gapdh, Hsp90ab1, 
Hprt1, Gusb) used for normalizing the PCR array data, and one 
negative control for genomic DNA contamination. The negative 
control primer set specifically detects non-transcribed, repetitive 
genomic DNA with a high level of sensitivity. Three wells of 
reverse transcription controls (RTCs) were used to verify the 
efficiency of the RT reaction with a qPCR assay that specifically 
detects template synthesized from the RNA control of the first 
strand synthesis kit. The replicate positive PCR controls (PPCs) 
were used to determine the efficiency of the polymerase chain 
reaction itself. These controls use a pre-dispensed artificial DNA 
sequence and a specific primer set to detect it. The two sets of 
replicate control wells (RTCs and PPCs) also test for inter-well 
and intra-plate consistency. The instrument’s software (MxPro 
Equipment Real Time Systems, Stratagene, GE, Co) calculates the 
threshold cycle (Ct) values for all of the genes in the array. Finally, 
it performs pair-wise comparisons by calculating fold changes 
in gene expression from the raw threshold cycle data using the 
ΔΔCt method. The method used in our study to determine the 
relative expression levels of the genes of interest in each sample 
is contained in the spreadsheet for PCR Array Data Analysis v3.3 
(SABiosciences – Qiagen, Co).
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Statistical analysis
The analysis of gene expression by real-time PCR 
used in this work represents a relative quantifi cation of genes of 
interest. To support the analysis six endogenous controls were 
part of the PCR reactions array for each of the samples tested; 
genes whose expression was used do not present a statistically 
signifi cant variation between samples. The control samples for 
each experimental group were used as reference baseline. The 
results were transformed into log2 scale for the calculation of 
averages and standard errors and for statistical analysis. Fold-
Change [2^ (- Delta Delta Ct)] is the normalized gene expression 
[2^ (- Delta Ct)] in the Test Sample divided the normalized gene 
expression [2^ (- Delta Ct)] in the Control Sample. Fold-Regulation 
represents fold-change results in a biologically meaningful way. It 
was considered that fold-change values greater than one indicates 
a positive or an up-regulation, and the fold-regulation is equal to 
the fold-change. The p values are calculated based on a Student’s 
t-test of the replicate 2^ (- Delta Ct) values for each gene in the 
control group and treatment groups. P values less than 0.05 was 
considered signifi cant in all experiments and indicated by symbols.
Results 
Table 1 shows the expression levels of ten genes related 
to endothelial cell biology in the rats belonging to the SG, IG, 
IG+IPC, IRG and IRG+IPC groups. This table lists the genes, 
gene abbreviations (alphabetical order), and gene descriptions 
along with the fold upregulation or down regulation of each gene 
and p values (bold). These data are plots in Figures 1 and 2. 
TABLE 1 - Expression of ten genes related to endothelial 
cell biology from rats of sham group (SG) versus ischemic 
group (IG) and sham group (SG) versus ischemic plus ischemic 
preconditioning group (IG+IPC).  Signifi cant values of fold up (+) 
or down (-) regulation was marked in bold [2^ (- Delta Ct].
#
Gene
Bank
Gene
Symbol
SG
x
IG
SG
x
IG+IPC
SG
x
IRG
SG
x
IRG+IPC
1 NM_017059 Bax -1.53 +2.30 +1.48 +5.45
2 NM_016993 Bcl2 +14.06 +3.12 +3.86 +4.82
3 NM_031535 Bcl2l1 -1.10 +3.48 +1.01 +7.48
4 NM_012762 Casp1 +35.11 +2.42 +100.68 +3.85
5 NM_012922 Casp3 -2.95 -1.87 +8.28 +1.35
6 NM_031775 Casp6 +3.79 -1.28 +6.86 +1.85
7 NM_057138 Cfl ar -1.12 -5.55 +41.60 -4.68
8 NM_139194 Fas +2.68 +1.49 +23.73 +1.04
9 XM_226742 Naip2 +12.68 +2.18 +1.31 +4.03
10 XM_574314 Plg +8.22 +1.77 +6.69 +4.89
FIGURE 1 - Scatter plot showing up (+) and down (-) fold-regulation 
of gene expression related to endothelial cell biology from rats of sham 
group (SG) versus ischemic group (IG) and  sham group (SG) versus 
ischemic plus ischemic preconditioning group (IG+IPC). 
FIGURE 2 - Scatter plot showing up (+) and down (-) fold-regulation 
of gene expression related to endothelial cell biology from rats of sham 
group (SG) versus ischemic/reperfusion group (IRG) and sham group 
(SG) versus ischemic/reperfusion plus ischemic preconditioning group 
(IRG+IPC). 
Discussion
Our results clearly demonstrate a down regulation 
of the genes related to endothelial cell biology in the rats that 
underwent IPC. The down regulation of these genes was observed 
in the IG+IPC and IRG+IPC. These results are consistent with the 
hypothesis that IPC promotes the decreased expression of genes 
that modulate the lesions produced by I/R. 
Whether the expression of certain genes corresponds 
to effective protein synthesis remains to be ascertained. Reports 
in the literature assume that proteins having matching or similar 
profi les tend to be functionally linked1. Those proteins that 
function together in a pathway or complex are likely to evolve in 
a correlated fashion. To enhance our analysis, we sought to group 
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genes according to the similarity of their previously characterized 
cellular activity. We focused on two clusters that are relevant to 
intestinal I/R: the caspase activation cluster (Bax, Casp1, Casp3, 
Casp6, Cflar) and the induction of apoptosis cluster (Bax, Casp1, 
Casp3, Plg, Fas). In addition, we assessed the expression of anti-
apoptotic genes (Bcl2, Bcl2l1, Naip2) that are important for 
intestinal I/R. 
Induction of apoptosis cluster (Bax, Casp1, Casp3, 
Casp6, Plg, Fas)
It is well established that apoptosis plays an essential 
role in regulating development, homeostasis, and immune defense 
by removing redundant or abnormal cells from organisms7,8. A 
delicate balance between pro-apoptotic mechanisms and anti-
apoptotic mechanisms determines whether a cell death signal can 
activate the execution of the apoptotic program9,10.
The cysteine-aspartic acid protease (caspase) family is 
involved in the signal transduction pathways of apoptosis, necrosis 
and inflammation.11 Caspases are the primary executioners of 
apoptosis. Death stimuli trigger the activation of initiator caspases, 
which in turn activate the effectors caspases12. The sequential 
activation of caspases plays a central role in the execution phase 
of apoptosis. There are two families of caspases: the inflammatory 
caspases and the apoptotic caspases, and each of these families 
can be further divided into initiator and effectors subgroups13. 
The initiator caspases (caspases 1, 4, 5, 8, 9, 10, 11, and 12) 
are activated by, and interact with, upstream adaptor molecules 
through protein-protein interaction domains known as CARD and 
DED13. Effectors caspases (caspases 3, 6, and 7) are responsible 
for cleaving downstream substrates and are sometimes referred to 
as the executioner caspases13. Initiator caspases, such as caspase 8, 
may be directly activated by death receptors such as Fas. Caspase 
9 is recruited to the apoptosome formed during apoptosis, whereas 
caspases 1 and 5 can form part of the inflammasome, a key 
mediator of cytokine processing during inflammation. 
Caspase 1 (Casp1) was identified based on its ability 
to proteolytically cleave and activate the inactive precursor 
of interleukin-1, a cytokine involved in processes such as 
inflammation, septic shock, and wound healing11. In the present 
study, Casp1 gene expression was up regulated in the IG (+35.11) 
and IRG (+100.68) but significantly reduced in the IG+IPC (+2.42) 
and IRG+IPC (+3.85). This decrease in Casp1 gene expression in 
the IPC groups can be interpreted as a lack of activation of the 
caspase cascade in response to cellular signaling stimulated in I/R 
injury, reinforcing the protective effect of IPC. The Casp3 protein 
cleaves and activates caspases 6, 7 and 9, and caspase 3 itself is 
processed by caspases 8, 9 and 1013. In our work, the Casp3 gene 
was up regulated in the IRG (+8.28) group, but its expression 
was significantly reduced in the IRG+IPC (+1.35). The caspase 
6 protein is processed by caspases 7, 8 and 10 and is thought 
to function as a downstream enzyme in the caspase activation 
cascade13. We observed that the Casp6 gene was up regulated in 
the IG (+3.79) and IRG (+100.68), but the expression of this gene 
was significantly reduced in the IG+IPC (+2.42) and IRG+IPC 
(+3.85). These findings regarding Casp 1, 3 and 6 expressions 
support the idea that cellular signaling stimulated by I/R injury is 
altered by IPC.
The protein encoded by the Cflar gene is a regulator of 
apoptosis11 that is structurally similar to caspase 8, however, the 
encoded protein lacks caspase activity and appears to be cleaved 
into two peptides by caspase 8. The apoptosis regulator protein 
c-FLIP is a crucial link between cell survival and cell death 
pathways in mammalian cells as it inhibits TNFRSF6-mediated 
apoptosis11. Full length and shorter isoforms have been shown either 
to induce apoptosis or to reduce TNFRSF-triggered apoptosis12. 
We observed that the Cflar gene was down regulated in the IG + 
IPC (-5.55) and IRG+IPC (-4.68) groups when compared to the 
IG and IRG. In the IRG, Cflar gene expression was up regulated, 
accounting for the protective effect of IPC.
The BAX protein forms a heterodimer with Bcl2 and is an 
apoptotic activator. Bax increases the opening of the mitochondrial 
voltage-dependent anion channel (VDAC), leading to a loss in 
membrane potential and the release of cytochrome c, which in turn 
activates the apoptotic cascade13. In our study, Bax gene expression 
was not down regulated in the IG + IPC and IRG+IPC when 
compared to the IG and IRG. Similar results were obtained for 
Fas gene expression. These results suggest that cellular signaling 
stimulated by IPC was unable to interfere with Bax and Fas gene 
expression. The protein encoded by the Fas gene is a member of 
the TNF receptor superfamily14. Known as a death receptor, FAS 
protein is located on the surface of cells15. The interaction of this 
receptor with its ligand results in the formation of a death-inducing 
signaling complex that includes FAS-associated death domain 
protein (FADD), caspase 8, and caspase 1014.
The protein encoded by the Plg gene is a secreted blood 
zymogen that is activated by proteolysis and converted to plasmin 
and angiostatin16. Plasmin dissolves fibrin in blood clots and is 
an important protease in many other cellular processes, whereas 
angiostatin inhibits angiogenesis16. In the present study, the Plg 
gene expression was upregulated in the IG (+8.22) and IRG 
(+6.69) groups, but IPC did not interfere with the expression of 
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this gene. 
Anti-apoptotic genes (Bcl2, Bcl2l1, Naip2)
Following TNF-R1 and Fas activation in mammalian cells, 
a balance between pro-apoptotic (BAX, BID, BAK, or BAD) and 
anti-apoptotic (BCL-Xl and BCL-2) members of the Bcl-2 family 
is established17. In the present study, Bcl2l1 gene expression was 
up regulated in the IG+IPC (+3.48) and IRG+IPC (+7.48) groups, 
but not in the IG and IRG, suggesting that IPC stimulated the 
upregulation of the anti-apoptotic protein encoded by the Bcl2l1 
gene. In contrast, Bcl2 gene expression was up regulated in the 
IG (+14.06), IRG (+3.86), IG+IPC (+3.12) and IRG+IPC (+4.82), 
suggesting that expression of the anti-apoptotic protein Bcl2 was 
not differentially stimulated by IPC. It is important to note that 
BCL-2 proteins can act as anti- or pro-apoptotic regulators that are 
involved in a wide variety of cellular activities10. 
Neuronal apoptosis inhibitory protein (NAIP) is a protein 
that inhibits the apoptosis of neurons and other cell types induced 
by a variety of signals18. At least three Naip genes encode full-
length mRNAs that correspond to possible functional proteins 
(NAIP1, 2 and 3)18. The NAIP mRNA transcripts are expressed in 
macrophage-rich tissues, such as spleen, lung, and liver, and are 
abundant in primary macrophages18. In the present study, Naip2 
gene expression was up regulated in the IRG+IPC (+4.03) when 
compared to the IRG (+1.31), suggesting that IPC stimulated the 
upregulation of the anti-apoptotic protein NAIP2.
Importantly, these findings confirm the protective effect 
of IPC against ischemia-mediated cell injury. The protective 
effect of IPC appears be correlated with the regulation of cellular 
adhesion, improvement in energetic and substrate metabolism, and 
activation of intracellular signal transduction
Conclusion
Ischemic preconditioning may protect against cell death 
caused by ischemia and reperfusion.
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